Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Jul-24 5:32 PM View:  | Scholar Rock Holding Corp (SRRK) | 27-Jun-24 | Grant | 13,500 | -- | -- | 143% 9.46K to 22.95K | |
| 07-Aug-23 6:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-23 | Sale | 4,057 | $185.85 | $753,986.00 | (15%) 27.35K to 23.29K | |
| 07-Aug-23 6:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Grant | 8,941 | -- | -- | 49% 18.41K to 27.35K | |
| 28-Apr-23 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 2,392 | $194.59 | $465,464.00 | (12%) 20.8K to 18.41K | |
| 28-Apr-23 5:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 5,312 | -- | -- | 34% 15.48K to 20.8K | |
| 14-Feb-23 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-23 | Option Exercise | 30,913 | $63.00 | $1,947,520.00 | 137% 22.62K to 53.53K | |
| 14-Feb-23 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-23 | Planned Option Sale | 30,913 | $215.97 | $6,676,250.00 | (58%) 53.53K to 22.62K | |
| 14-Feb-23 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-23 | Sale (Planned) | 7,131 | $215.97 | $1,540,070.00 | (32%) 22.62K to 15.48K | |
| 07-Dec-22 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Dec-22 | Payment of Exercise | 1,324 | $226.20 | $299,489.00 | (6%) 23.94K to 22.62K | |
| 07-Dec-22 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Dec-22 | Option Exercise | 5,079 | $59.05 | $299,938.00 | 27% 18.86K to 23.94K | |
| 05-Aug-22 4:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-22 | Payment of Exercise | 6,052 | $191.73 | $1,160,340.00 | (24%) 24.91K to 18.86K | |
| 05-Aug-22 4:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-22 | Grant | 13,183 | -- | -- | 112% 11.73K to 24.91K | |
| 23-Dec-21 5:23 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Dec-21 | Market Sale (Planned) | 2,879 | $190.93 | $549,698.00 | (20%) 14.61K to 11.73K | |
| 23-Dec-21 5:23 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Dec-21 | Payment of Exercise | 2,538 | $189.00 | $479,690.00 | (15%) 17.15K to 14.61K | |
| 23-Dec-21 5:23 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Dec-21 | Grant | 5,417 | -- | -- | 46% 11.73K to 17.15K | |
| 11-Aug-21 10:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Aug-21 | Option Exercise | 10,834 | $63.00 | $682,542.00 | 92% 11.73K to 22.56K | |
| 11-Aug-21 10:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Aug-21 | Market Option Sale (Planned) | 10,834 | $200.00 | $2,166,800.00 | (48%) 22.56K to 11.73K | |
| 22-Jun-21 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Jun-21 | Option Exercise | 11,804 | $61.29 | $723,495.00 | 81% 14.63K to 26.44K | |
| 22-Jun-21 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Jun-21 | Market Option Sale (Planned) | 11,804 | $175.00 | $2,065,700.00 | (45%) 26.44K to 14.63K | |
| 22-Jun-21 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Jun-21 | Market Sale (Planned) | 2,904 | $175.00 | $508,200.00 | (20%) 14.63K to 11.73K | |
| 21-Apr-21 6:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Apr-21 | Market Sale (Planned) | 2,732 | $136.95 | $374,135.00 | (16%) 17.37K to 14.63K | |
| 21-Apr-21 6:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-21 | Payment of Exercise | 2,351 | $131.85 | $309,983.00 | (12%) 19.72K to 17.37K | |
| 21-Apr-21 6:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Apr-21 | Grant | 5,083 | -- | -- | 28% 18.34K to 23.42K | |
| 21-Apr-21 6:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Apr-21 | Market Sale (Planned) | 3,706 | $137.67 | $510,192.00 | (16%) 23.42K to 19.72K | |
| 16-Feb-21 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Feb-21 | Payment of Exercise | 1,710 | $155.81 | $266,441.00 | (9%) 20.05K to 18.34K | |
| 16-Feb-21 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Feb-21 | Grant | 5,416 | -- | -- | 37% 14.63K to 20.05K | |
| 01-Oct-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Sep-20 | Option Exercise | 971 | $42.22 | $40,995.60 | 7% 14.63K to 15.61K | |
| 01-Oct-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Sep-20 | Market Option Sale (Planned) | 971 | $140.00 | $135,940.00 | (6%) 15.61K to 14.63K | |
| 24-Jun-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Jun-20 | Option Exercise | 970 | $42.22 | $40,953.40 | 7% 14.63K to 15.6K | |
| 24-Jun-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Jun-20 | Market Option Sale (Planned) | 970 | $151.07 | $146,536.00 | (6%) 15.6K to 14.63K | |
| 22-Apr-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-20 | Option Exercise | 21,971 | $42.22 | $927,616.00 | 150% 14.63K to 36.6K | |
| 22-Apr-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-20 | Market Option Sale (Planned) | 21,971 | $140.00 | $3,075,940.00 | (60%) 36.6K to 14.63K | |
| 09-Apr-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Grant | 5,417 | -- | -- | 46% 11.73K to 17.15K | |
| 09-Apr-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Payment of Exercise | 2,513 | $104.82 | $263,410.00 | (15%) 17.15K to 14.63K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Feb-20 | Option Exercise | 22,750 | $42.22 | $960,505.00 | 179% 12.69K to 35.44K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Feb-20 | Market Option Sale (Planned) | 22,750 | $125.00 | $2,843,750.00 | (64%) 35.44K to 12.69K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Feb-20 | Market Sale (Planned) | 958 | $125.00 | $119,750.00 | (8%) 12.69K to 11.73K | |
| 07-Aug-19 4:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Jul-19 | Acquisition (other) | 48 | -- | -- | < 1% 12.64K to 12.69K | |
| 07-Jun-19 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Apr-19 | Acquisition (other) | 51 | -- | -- | < 1% 12.59K to 12.64K | |
| 07-Jun-19 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Oct-18 | Acquisition (other) | 21 | -- | -- | < 1% 12.57K to 12.59K | |
| 14-Aug-18 6:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Aug-18 | Grant | 1,724 | -- | -- | 15% 11.61K to 13.33K | |
| 14-Aug-18 6:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Aug-18 | Payment of Exercise | 766 | $90.95 | $69,667.70 | (6%) 13.33K to 12.57K | 8% |
| 14-Aug-18 6:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-18 | Acquisition (other) | 29 | -- | -- | < 1% 11.58K to 11.61K | |
| 14-Aug-18 6:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Apr-18 | Acquisition (other) Duplicate | 28 | -- | -- | < 1% 11.55K to 11.58K | |
| 16-Mar-18 5:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 14-Mar-18 | Option Exercise | 88,554 | $17.03 | $1,507,840.00 | 767% 11.55K to 100.11K | |
| 16-Mar-18 5:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 14-Mar-18 | Market Option Sale (Planned) | 88,554 | $143.10 | $12,672,100.00 | (88%) 100.11K to 11.55K | 42% |
| 21-Dec-17 4:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Dec-17 | Gift | 320 | -- | -- | (3%) 11.87K to 11.55K | |
| 01-Nov-17 5:33 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 30-Oct-17 | Option Exercise | 33,666 | $21.35 | $718,769.00 | 284% 11.87K to 45.54K | |
| 01-Nov-17 5:33 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 30-Oct-17 | Market Option Sale (Planned) | 33,666 | $121.46 | $4,088,970.00 | (74%) 45.54K to 11.87K | 31% |
| 15-Jun-17 5:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Jun-17 | Payment of Exercise | 430 | $74.31 | $31,953.30 | (4%) 12.25K to 11.82K | (12%) |